As of November 2023, it was added to the FDA drug shortage list
They include nausea, vomiting, diarrhea, stomach pain, and constipation
Novo Nordisk and Eli Lilly currently dominate this market and are expected to maintain a combined share of about 90% due to strong product offerings and continuous innovation in clinical trials
GLP-1 Analogues Market Regional Analysis North America Holds the Largest Share in the GLP-1 Analogues Market North America dominates the GLP-1 analogues market with an estimated market share of over 76.05%, primarily driven by high obesity and diabetes prevalence, strong healthcare infrastructure, and early adoption of innovative therapies U.S
The minimum order quantity of AdvaLife supplements varies depending on the product, formulation and/or dosage form